Related references
Note: Only part of the references are listed.Increased Transendothelial Transport of CCL3 Is Insufficient to Drive Immune Cell Transmigration through the Blood-Brain Barrier under Inflammatory Conditions In Vitro
Maxime De Laere et al.
MEDIATORS OF INFLAMMATION (2017)
Harnessing the properties of dendritic cells in the pursuit of immunological tolerance
Christopher Horton et al.
BIOMEDICAL JOURNAL (2017)
Immunomodulatory Effects of 1,25-Dihydroxyvitamin D3 on Dendritic Cells Promote Induction of T Cell Hyporesponsiveness to Myelin-Derived Antigens
Wai-Ping Lee et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Skewing dendritic cell differentiation towards a tolerogenic state for recovery of tolerance in rheumatoid arthritis
Katina Schinnerling et al.
AUTOIMMUNITY REVIEWS (2015)
Intraperitoneal Administration of Autologous Tolerogenic Dendritic Cells for Refractory Crohn's Disease: A Phase I Study
Aranzazu Jauregui-Amezaga et al.
JOURNAL OF CROHNS & COLITIS (2015)
Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients
Helen Benham et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Electroporated Antigen-Encoding mRNA Is Not a Danger Signal to Human Mature Monocyte-Derived Dendritic Cells
Stefanie Hoyer et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
Beneficial Effect of Tolerogenic Dendritic Cells Pulsed with MOG Autoantigen in Experimental Autoimmune Encephalomyelitis
Maria Jose Mansilla et al.
CNS NEUROSCIENCE & THERAPEUTICS (2015)
Tolerogenic dendritic cell vaccines to treat autoimmune diseases: Can the unattainable dream turn into reality?
Ilse Van Brussel et al.
AUTOIMMUNITY REVIEWS (2014)
DARC shuttles inflammatory chemokines across the blood-brain barrier during autoimmune central nervous system inflammation
Carsten Minten et al.
BRAIN (2014)
Circulating dendritic cells of multiple sclerosis patients are proinflammatory and their frequency is correlated with MS-associated genetic risk factors
Kristof Thewissen et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Multiple Sclerosis: Current and Emerging Disease-Modifying Therapies and Treatment Strategies
Dean M. Wingerchuk et al.
MAYO CLINIC PROCEEDINGS (2014)
Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now?
C. M. U. Hilkens et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
Targeting of 111In-Labeled Dendritic Cell Human Vaccines Improved by Reducing Number of Cells
Erik H. J. G. Aarntzen et al.
CLINICAL CANCER RESEARCH (2013)
Pathology and disease mechanisms in different stages of multiple sclerosis
Hans Lassmann
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
A short protocol using dexamethasone and monophosphoryl lipid A generates tolerogenic dendritic cells that display a potent migratory capacity to lymphoid chemokines
Paulina Garcia-Gonzalez et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Recognition of damage-associated molecular patterns related to nucleic acids during inflammation and vaccination
Nao Jounai et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2013)
Nucleic acids and endosomal pattern recognition: how to tell friend from foe?
Eva Brencicova et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2013)
Regulatory multitasking of tolerogenic dendritic cells - lessons taken from vitamin D3-treated tolerogenic dendritic cells
Tatiana Nikolic et al.
FRONTIERS IN IMMUNOLOGY (2013)
IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction - A comparative study of human clinical-applicable DC
Martine A. Boks et al.
CLINICAL IMMUNOLOGY (2012)
Expression and Regulation of Chemoldnes in Murine and Human Type 1 Diabetes
Suparna A. Sarkar et al.
DIABETES (2012)
Fulfilling the dream: tolerogenic dendritic cells to treat multiple sclerosis
Catharina C. Gross et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks
Deepali Malhotra et al.
NATURE IMMUNOLOGY (2012)
Progressive multiple sclerosis: pathology and pathogenesis
Hans Lassmann et al.
NATURE REVIEWS NEUROLOGY (2012)
Inflammation, demyelination, and degeneration - Recent insights from MS pathology
Christine Stadelmann et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Phase 1 (Safety) Study of Autologous Tolerogenic Dendritic Cells in Type 1 Diabetic Patients
Nick Giannoukakis et al.
DIABETES CARE (2011)
Immune tolerance in multiple sclerosis
Joan M. Goverman
IMMUNOLOGICAL REVIEWS (2011)
Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis
Rachel A. Harry et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Development of Dendritic Cell-Based Immunotherapy for Autoimmunity
Catharien M. U. Hilkens et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2010)
Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells
Mahdia Benkhoucha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Limited Amounts of Dendritic Cells Migrate into the T-Cell Area of Lymph Nodes but Have High Immune Activating Potential in Melanoma Patients
Pauline Verdijk et al.
CLINICAL CANCER RESEARCH (2009)
Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: Differential role for PD-L1
Wendy W. J. Unger et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
CD11c+CD11b+ dendritic cells play an important role in intravenous tolerance and the suppression of experimental autoimmune encephalomyelitis
Hongmei Li et al.
JOURNAL OF IMMUNOLOGY (2008)
Transcellular transport of CCL2 across brain microvascular endothelial cells
Shujun Ge et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Balancing between immunity and tolerance: An interplay between dendritic cells, regulatory T cells, and effector T cells
Nathalie Cools et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
CCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis
Antonio Manzo et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy
IJM de Vries et al.
NATURE BIOTECHNOLOGY (2005)
Biodistribution of radiolabelled human dendritic cells injected by various routes
V Quillien et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
mRNA is an endogenous ligand for Toll-like receptor 3
K Karikó et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Regulation of dendritic cell migration to the draining lymph node:: Impact on T lymphocyte traffic and priming
A Martín-Fontecha et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease
C Banks et al.
JOURNAL OF PATHOLOGY (2003)
Dendritic cells, chemokine receptors and autoimmune inflammatory diseases
PD Cravens et al.
IMMUNOLOGY AND CELL BIOLOGY (2002)
Elevated expression of CCR5 by myeloid (CD11c(+)) blood dendritic cells in multiple sclerosis and acute optic neuritis
M Pashenkov et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2002)
Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages
E Kriehuber et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Cutting edge: Selective usage of chemokine receptors by plasmacytoid dendritic cells
G Penna et al.
JOURNAL OF IMMUNOLOGY (2001)
Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells
VFI Van Tendeloo et al.
BLOOD (2001)
Macrophage inflammatory protein-1α (MIP-1α), MIP-1β, and RANTES mRNA semiquantification and protein expression in active demyelinating multiple sclerosis (MS) lesions
LA Boven et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2000)
Share Paper
